ACS is committed to helping combat the global COVID-19 pandemic with initiatives and free resources. Learn More

Rodney J.Y. Ho

Rodney JY Ho

Dr. Rodney J.Y. Ho is a professor and presidential entrepreneurial fellow of the University of Washington, and holds appointments at the Fred Hutchinson Cancer Research Center. He is also an expert on pharmacology and systems approach to drug targeting and long-acting therapy. His research aims to improve the therapeutic efficacy and safety of viral and cancer drugs, medical diagnostic agents and vaccines. He is an elected fellow of the American Association for the Advancement of Science (AAAS) and the American Association of Pharmaceutical Scientists (AAPS). He studies the relationships between drug target distribution and its relationship to disease development in cancer, AIDS, and neurological disorders. Building on this understanding, he has developed a systems Approach to Drug Delivery and Targeting. He is known for his expertise in bio-therapeutics, lipid-drug and -protein interactions, liposomes, drug-combination nanoparticles, pharmacokinetics, and the interplay between tissue targets and drug penetration. His research has led to enhanced HIV, cancer, and pain medication potency and safety. In addition, he is an editor of the Journal of Pharmaceutical Sciences, and author of “Biotechnology and Biopharmaceuticals: Transforming Proteins and Gene into Drugs.” He has received top honors including the Paul Dawson Biotechnology life-time achievement award, the AAPS Biotechnology Research achievement, one of AAPS’s highest recognitions, and The Volwiler Research Achievement Award.